Symbols

MDLN

Medline·NASDAQ

--(--)

MDLN fundamentals

MDLN Q4 2025 Earnings

Medline (MDLN) released its earnings on Feb 25, 2026: revenue was 7.79B (YoY --), beat estimates; EPS was -0.01 (YoY --), missed estimates.

Revenue / YoY

7.79B

EPS / YoY

-0.01

Report date

Feb 25, 2026

MDLN Earnings Call Summary for Q4,2025

Revenue Growth: 12% YoY to $28.4 billion, driven by new signings and Medline Brand conversions.
Automation Leap: 19 AutoStore facilities, 2,100 robots, and Symbotic bulk-picking pilot to boost efficiency.
Tariff Headwinds: 2026 incremental impact $200 million, partially mitigated by production shifts and pricing.
Strategic Wins: Consolidated IDN win and $2.4B signings highlight end-to-end care model success.
Financial Strength: $7B IPO reduces leverage, with $1.3B free cash flow and $3.5B EBITDA in 2025.

Earnings

EPS

Revenue

Revenue & Expenses

MDLN has released its 2025 Q4 earnings report, with revenue of 7.79B, reflecting a YoY change of 14.78%, and net profit of 180.00M, showing a YoY change of -37.72%. The Sankey diagram below clearly presents MDLN's revenue sources and cost distribution.

Key Indicators

Medline (MDLN) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Medline (MDLN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Medline (MDLN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Medline (MDLN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown